BioDelivery Sciences International Inc logo

BDSI - BioDelivery Sciences International Inc News Story

$3.18 0.0  0.0%

Last Trade - 10/05/21

Small Cap
Market Cap £227.2m
Enterprise Value £203.7m
Revenue £110.8m
Position in Universe 4065th / 6853

BRIEF-Biodelivery Sciences announces FDA approval of Onsolis

Thu 13th August, 2015 12:00pm
Aug 13 (Reuters) - BioDelivery Sciences International Inc  BDSI.O : 
 * Announces FDA approval of new formulation of onsolis (fentanyl buccal 
   soluble film) cii 
 * Says approval of new formulation expected to allow onsolis to return to U.S. 
   market in 2016 
 * Says meda retains the rights to onsolis outside the U.S., where it is 
   marketed in the e.u. as breakyl 
 * Says onsolis is separately licensed by bdsi in Taiwan and South Korea 
 * Source text for Eikon  ID:nPn2js3WS  
 * Further company coverage  BDSI.O   
    ((Bengaluru Newsroom; +1 646 223 8780))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.